Skip to main content
Clinical Trials/TCTR20180703002
TCTR20180703002
Active, not recruiting
Phase 1

Evaluation the sensitivity and specificity of a novel diagnostic kit for the detection of placental alpha-microglobulin-1 (PAMG-1) in the prediction of preterm birth

no0 sites160 target enrollmentJuly 3, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Preterm birth
Sponsor
no
Enrollment
160
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 3, 2018
End Date
June 30, 2018
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
no

Eligibility Criteria

Inclusion Criteria

  • 1\. Preterm labour during gesttaional age about 20\-36 weeks of gestation.
  • 2\. No leakage of amniotic fluid.
  • 3\. cervical opening not greater than 3 cm.

Exclusion Criteria

  • 1\. Pregnant women less than 18 years old.
  • 2\. Pregnant women with leakage of amniotic fluid or bleeding per vagina
  • 3\. Pregnant with previous digital examination.

Outcomes

Primary Outcomes

Not specified

Similar Trials